Last reviewed · How we verify
Amyleine (amylocaine)
Amyleine (generic name: amylocaine) is a amylocaine drug. It is currently in unknown development.
Amyleine works by blocking sodium channels in nerve cells to prevent pain signals from being transmitted.
Amylocaine, also known as Stovaine, is a synthetic local anesthetic that was the first of its kind, synthesized and patented by Ernest Fourneau in 1903. It was primarily used in spinal anesthesia.
At a glance
| Generic name | amylocaine |
|---|---|
| Drug class | amylocaine |
| Therapeutic area | Neuroscience |
| Phase | unknown |
Mechanism of action
Imagine your nerves are like a telephone line, and pain signals are like phone calls. Amyleine acts like a switch that turns off the phone line, so the pain signals can't get through. This temporary blockage of pain signals is what allows amyleine to provide local anesthesia.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Amyleine CI brief — competitive landscape report
- Amyleine updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Amyleine
What is Amyleine?
How does Amyleine work?
What is the generic name of Amyleine?
What drug class is Amyleine in?
What development phase is Amyleine in?
Related
- Drug class: All amylocaine drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Neuroscience
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing